A Study in Healthy Volunteers to Assess the Effect of Fedovapagon on the QT/QTC Interval
Clinical trial NCT02537288 · COMPLETED
Trial details
- NCT number
- NCT02537288
- Sponsor
- Vantia Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2015-12-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.